Bausch & Lomb announce new corporate VP
ROCHESTER, N.Y. Bausch & Lomb on Wednesday named Susan Roberts as a corporate vice president, the company announced. She is the company’s chief compliance officer, having been named to this post in 2006, and heads the global pharmacovigilance and safety surveillance groups.
Roberts joined Bausch & Lomb in 1995 after several years in private practice as a trial lawyer at Harter, Secrest & Emery. She then held positions of increasing responsibility in the Bausch & Lomb law department, including serving as vice president and assistant general counsel.
Roberts holds a J.D. cum laude from the Albany Law School of Union University and a Bachelor’s degree from Binghamton University.
MOM Enterprises Launches Morning Sickness Magic
SAN RAFAEL, Calif. MOM Enterprises last week announced the launch of its morning sickness dietary supplement called Morning Sickness Magic.
“This is the first formula to combine B6, ginger, and other anti-nausea ingredients,” stated Roshan Kaderali, registered nurse and developer of the product. “It’s safe for mothers and their unborn babies—obstetricians across the country are recommending it and distributing it to their patients. It’s actually been the best selling morning sickness formula in the U.S. for the past 5 years. We’ve received tons of emails from expectant mothers who are so relieved that their morning sickness has disappeared,” she said.
According to the American College of Obstetricians and Gynecologists, morning sickness affects between as many as 70 percent of women.
Plan B sees increase in Rx-to-OTC availability
NEW YORK Over-the-counter availability of Plan B has increased access to the emergency contraceptive, a survey published in the November issue of the American Journal of Obstetrics & Gynecology reported.
The survey, originally published online June 16, found that only 8 percent of pharmacies were unable to provide Plan B within 24 hours in 2007, as compared to 23 percent of pharmacies that were unable to produce the emergency contraceptive in 2005. And the total refusal rate in 2007 was half that in 2005, 2 percent vs. 4 percent.
The Food and Drug Administration approved the Rx-to-OTC switch of Plan B in 2006.
Pharmacists from Atlanta and Philadelphia were interviewed at 1,087 pharmacies in 2005 and at 795 pharmacies in 2007.